Abstract
Guidelines recommend a positive strategy based on symptom criteria to diagnose patients with irritable bowel syndrome (IBS). We conducted a randomized noninferiority trial to determine whether a positive diagnostic strategy is noninferior to a strategy of exclusion, with regard to patients' health-related quality of life (HRQOL).
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association |
| Vol/bind | 11 |
| Udgave nummer | 8 |
| Sider (fra-til) | 956-62.e1 |
| ISSN | 1542-3565 |
| DOI | |
| Status | Udgivet - 2013 |
| Udgivet eksternt | Ja |